Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial

Takaki Yoshikawa, Kei Muro, Kohei Shitara, Do Youn Oh, Yoon Koo Kang, Hyun Cheol Chung, Toshihiro Kudo, Keisho Chin, Shigenori Kadowaki, Yasuo Hamamoto, Shuichi Hironaka, Kazuhiro Yoshida, Chia Jui Yen, Yasushi Omuro, Li Yuan Bai, Kaijiro Maeda, Akichika Ozeki, Reigetsu Yoshikawa, Yuko Kitagawa

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences